Hana Golding

This inventor holds 13 USPTO granted patents and 2 published patent applications and 5 EPO patents. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2009-2022.

USPTO Granted Patents = 13 (Patent Applications = 2)

% Patents Active = 76.9

EPO Patents = 5 (Patent Applications = 6)

Average Co-Inventor Count = 2.1

ph-index = 1

Forward Citations = 3(Granted Patents)

Company Filing History:

13 out of 3,690

The United States of America, as Represented by the Secretary, Department of Health and Human Services

patents

Years Active: 2009-2022

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11478542 - Immunogenic RSV polypeptides (2022-10-25),

2. 10744193 - Immunogenic RSV polypeptides (2020-08-18),

3. 10377798 - Recombinant respiratory syncytial virus G protein fragments (2019-08-13),

4. 9896484 - Influenza virus recombinant proteins (2018-02-20),

5. 9163068 - Influenza virus recombinant proteins (2015-10-20),

6. 9121855 - Method for the detection of HIV-1 antibodies utilizing a peptide containing a novel gp41 epitope (2015-09-01),

7. 8980546 - Method for the detection of HIV-1-specific antibodies utilizing a Vpu polypeptide (2015-03-17),

8. 8778847 - Immunogenic peptides of influenza virus (2014-07-15),

9. 8722324 - Methods for the detection of HIV-1-specific antibodies employing GP41 polypeptides (2014-05-13),

10. 8282926 - CCR5-specific antibodies with HIV neutralizing activity that recognize a linear dodecapeptide that mimics a conformational epitope in the second extracellular loop of CCR5 (2012-10-09),

11. 7888003 - Methods for the detection of HIV-1 antibodies employing polypeptides obtained from gag P6 protein (2011-02-15),

12. 7700273 - Peptidomimetics that mimic a conformational-dependent neutralizing epitope of the human immunodeficiency virus (HIV) CCR5 coreceptor (2010-04-20),

13. 7510715 - Protozoan derived compositions and methods of use thereof (2009-03-31),

Title: The Innovative Contributions of Hana Golding

Introduction

Hana Golding is a prominent inventor based in Rockville, MD (US). She has made significant contributions to the field of immunology, particularly in the development of immunogenic compositions targeting respiratory syncytial virus (RSV). With a total of 13 patents to her name, Golding's work is recognized for its potential impact on public health.

Latest Patents

One of her latest patents involves immunogenic RSV polypeptides. This invention provides immunogenic compositions that comprise an immune stimulant and an RSV oligopeptide or an unglycosylated RSV polypeptide. The RSV oligopeptides are detailed in SEQ ID NO: 3-33. Additionally, the unglycosylated RSV polypeptide may consist essentially of the ectodomain of an RSV G protein, as shown in SEQ ID NO: 2, or the ectodomain of an RSV F protein, such as that depicted in SEQ ID NO: 39.

Career Highlights

Hana Golding is currently affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. Her work at this esteemed institution has allowed her to focus on groundbreaking research that addresses critical health challenges.

Collaborations

Some of her notable coworkers include Surender Khurana and Julio Aliberti. Their collaborative efforts contribute to the advancement of research in immunology and related fields.

Conclusion

Hana Golding's innovative work and dedication to her field have led to significant advancements in the understanding and treatment of respiratory syncytial virus. Her contributions continue to inspire future research and development in immunology.